Zobrazeno 1 - 8
of 8
pro vyhledávání: '"María Gracia Mateo"'
Autor:
José Ramón Santos, Maria Casadellà, Marc Noguera-Julian, Rafael Micán-Rivera, Pere Domingo, Antonio Antela, Joaquin Portilla, Jesús Sanz, Marta Montero-Alonso, Jordi Navarro, Mar Masiá, Nieves Valcarce-Pardeiro, Antonio Ocampo, Laura Pérez-Martínez, Coral García-Vallecillos, María Jesús Vivancos, Arkaitz Imaz, José Antonio Iribarren, José Hernández-Quero, Judit Villar-García, Pilar Barrufet, Roger Paredes, INSTINCT study group, Mariona Perera, Anna Chamorro, Cristina Miranda, Nástor Sánchez, Anna Garcı́á, Núria Pérez, Juan González Garcı́á, María del Mar Gutiérrez, María Gracia Mateo, Elena Losada, Sergio Reus, Vicente Boix, Diego Torrús, Esperanza Merino, Angela Gutiérrez Liarte, Adrià Curran, Félix Gutiérrez, Anna Mariño Callejo, Alvarez Diaz Hortensia, Antonio Ocampo Hermida, Celia Miralles, Laura Labajo Leal, Guillermo Pousada, José Ramon Blanco, José Antonio Oteo, Ibarra Valvanera, Mercedes Sanz, Luis Metola, Juan Pascua, Daniel Podzamczer, Camila Piatti, Maialen Ibarguren, Laia Arbones, Marta Ruiz, Sara Cervanntes, Helena Pera, Jessica Toro, Nuria Perez-Alvarez, Anna Garcia
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
IntroductionSecond-generation integrase strand transfer inhibitors (INSTIs) are preferred treatment options worldwide, and dolutegravir (DTG) is the treatment of choice in resource-limited settings. Nevertheless, in some resource-limited settings, th
Externí odkaz:
https://doaj.org/article/63e60100a5744c33a4e4d6da36790d78
Autor:
Rubén Cereijo, José Miguel Gallego-Escuredo, Ricardo Moure, Joan Villarroya, Joan Carles Domingo, Joan Fontdevila, Esteban Martínez, Maria del Mar Gutiérrez, María Gracia Mateo, Marta Giralt, Pere Domingo, Francesc Villarroya
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136571 (2015)
Highly active antiretroviral therapy has remarkably improved quality of life of HIV-1-infected patients. However, this treatment has been associated with the so-called lipodystrophic syndrome, which conveys a number of adverse metabolic effects and m
Externí odkaz:
https://doaj.org/article/549b33892c3944f2ac7bfde03ff2fc6c
Autor:
Anna, De Dios, Montserrat, Masip, Neus, Pagès-Puigdemont, Pau, Riera, María, Gracia Mateo, María Del Mar, Gutiérrez, Maria Antònia, Mangues, Mar, Gomis-Pastor
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 46(7)
People living with human immunodeficiency virus could particularly benefit from mobile health (mHealth). The objective of the study was to contribute to the design and development of a new standard of care for people living with human immunodeficienc
Autor:
Pere Domingo, María Gracia Mateo, Joan Villarroya, Rubén Cereijo, Ferran Torres, Joan C. Domingo, Laura Campderrós, José M. Gallego-Escuredo, María del Mar Gutierrez, Isabel Mur, Noemí Corbacho, Francesc Vidal, Francesc Villarroya, Marta Giralt
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Clinical Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 549
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Universidad de las Islas Baleares
Journal of Clinical Medicine, Vol 11, Iss 549, p 549 (2022)
Universidad de Barcelona
Journal of Clinical Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 549
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Universidad de las Islas Baleares
Journal of Clinical Medicine, Vol 11, Iss 549, p 549 (2022)
Objective: People living with HIV (PLWH) have an increased cardiovascular risk (CVR) owing to dyslipidemia, insulin resistance, metabolic syndrome, and HIV/combination antiretroviral therapy (cART)-associated lipodystrophy (HALS). Atherosclerosis and
Autor:
Pere Domingo, Marta Giralt, Aleix Gavaldà-Navarro, Albert Blasco-Roset, Alejandro Delgado-Anglés, José Miguel Gallego-Escuredo, Maria Del Mar Gutiérrez, Maria Gracia Mateo, Rubén Cereijo, Joan Carles Domingo, Francesc Villarroya, Joan Villarroya
Publikováno v:
Adipocyte, Vol 11, Iss 1, Pp 143-152 (2022)
Lipodystrophy is a major disturbance in people living with HIV-1 (PLWH). Several systemic alterations in PLWH are reminiscent of those that occur in ageing. It is unknown whether the lipodystrophy in PLWH is the consequence of accelerated ageing in a
Externí odkaz:
https://doaj.org/article/61ce931dcec94416a091169e2a981474
Autor:
Pere Domingo, Maria del Carmen Cabeza, Ferran Torres, Juliana Salazar, Maria del Mar Gutierrez, Maria Gracia Mateo, Esteban Martínez, Joan Carles Domingo, Irene Fernandez, Francesc Villarroya, Esteban Ribera, Francesc Vidal, Montserrat Baiget
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e57347 (2013)
BackgroundLow expression thymidylate synthase (TS) polymorphism has been associated with increased stavudine triphosphate intracellular (d4T-TP) levels and the lipodystrophy syndrome. The use of d4T has been associated with acute pancreatitis and per
Externí odkaz:
https://doaj.org/article/e40d6c4aa22f4e038fe92bb0db00f7c6
Autor:
Pere Domingo, Maria Gracia Mateo, Alain Pruvost, Ferran Torres, Juliana Salazar, Maria Del Mar Gutierrez, Ma Carmen Cabeza, Joan Carles Domingo, Irene Fernandez, Francesc Villarroya, Francesc Vidal, Montserrat Baiget, Oscar de la Calle-Martín
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e67035 (2013)
PURPOSETo assess in a cohort of Caucasian patients exposed to stavudine (d4T) the association of polymorphisms in pyrimidine pathway enzymes and HLA-B*40∶01 carriage with HIV/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syn
Externí odkaz:
https://doaj.org/article/f18a670e999e494f817578104172cbe9
Autor:
Pere Domingo, Javier Torres-Torronteras, Virginia Pomar, Marta Giralt, Joan Carles Domingo, Maria Del Mar Gutierrez, José M Gallego-Escuredo, Maria Gracia Mateo, Pedro Cano-Soldado, Irene Fernandez, Marçal Pastor-Anglada, Francesc Vidal, Francesc Villarroya, Antoni Andreu, Ramon Marti
Publikováno v:
PLoS ONE, Vol 5, Iss 11, p e13896 (2010)
BackgroundUridine has been advocated for the treatment of HIV-1/HAART-associated lipodystrophy (HALS), although its metabolism in HIV-1-infected patients is poorly understood.MethodsPlasma uridine concentrations were measured in 35 controls and 221 H
Externí odkaz:
https://doaj.org/article/22a61b1f92254da39add10ac81c125f9